Publications by authors named "Pierre Fons"

Claim this Profile
T
Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy.
Michael R Paillasse, Michael Esquerré, Florie A Bertrand, Céline Poussereau-Pomié, Mélanie Pichery, Pierre Fons

Cancer Res Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted identification of sialoglycoproteins in hypoxic endothelial cells and validation in zebrafish reveal roles for proteins in angiogenesis.
Nicolas Delcourt, Celia Quevedo, Christelle Nonne, Pierre Fons, Donogh O'Brien

J Biol Chem· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor vasculature is regulated by FGF/FGFR signaling-mediated angiogenesis and bone marrow-derived cell recruitment: this mechanism is inhibited by SSR128129E, the first allosteric antagonist of FGFRs.
Pierre Fons, Geneviève Gueguen-Dorbes, Jean-Pascal Herault, Fabien Geronimi, Joël Tuyaret

J Cell Physiol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated image analysis of in vitro angiogenesis assay.
Marie-Laure Boizeau, Pierre Fons, Lionel Cousseins, Josette Desjobert, David Sibrac

J Lab Autom· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties.
Françoise Bono, Frederik De Smet, Corentin Herbert, Katrien De Bock, Maria Georgiadou, Pierre Fons

Cancer Cell· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis.
Fan Zhang, Zhongshu Tang, Xu Hou, Johan Lennartsson, Yang Li, Pierre Fons

Proc Natl Acad Sci U S A· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble HLA-G and control of angiogenesis.
Philippe Le Bouteiller, Pierre Fons, Jean-Pascal Herault, Françoise Bono, Sophie Chabot

J Reprod Immunol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells.
Pierre Fons, Sophie Chabot, Judith E Cartwright, Francoise Lenfant, Fatima L'Faqihi

Blood· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration.
Benoit Favier, Antoine Alam, Pauline Barron, Jacques Bonnin, Patricia Laboudie, Pierre Fons

Blood· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors.
Xuri Li, Marc Tjwa, Lieve Moons, Pierre Fons, Agnes Noel

J Clin Invest· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterodimerization with vascular endothelial growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3 activity.
Antoine Alam, Jean-Pascal Herault, Pauline Barron, Benoit Favier, Pierre Fons

Biochem Biophys Res Commun· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF-R2 and neuropilin-1 are involved in VEGF-A-induced differentiation of human bone marrow progenitor cells.
Pierre Fons, Jean-Pascal Herault, Nathalie Delesque, Joēl Tuyaret, Françoise Bono

J Cell Physiol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis